{'fraction_non_alphanumeric': 0.012727272727272728, 'fraction_numerical': 0.0, 'mean_word_length': 5.63855421686747, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Thrombolytic therapy of the acute myocardial infarction by cabicinase

The necessity to perform the systemic thrombolysis to patients with acute myocardial infarction is emphasized. The most effective and save thrombolytic agent is cabicanase. The recommendations for practical physicians are worthy of notice. The control of blood coagulability velocity and hemorrhage lingering is obligatory in the performance of thrombolysis; if it is possible, thrombelastograms are to be studied. It is essential to know well the contradictions to thrombolysis.